Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner

Amber L. Beitelshees, Julie A. Johnson, Megan L. Hames, Yan Gong, Rhonda M. Cooper-Dehoff, Jun Wu, Sharon Cresci, Cynthia X. Ma, Carl J. Pepine, Michael A. Province, John A. Spertus, Howard L. McLeod

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Introduction: CYP19A1 encodes aromatase, the enzyme responsible for the conversion of androgens to estrogens, and may play a role in variation in outcomes among men and women with cardiovascular disease. We sought to examine genetic variation in CYP19A1 for its potential role in sex differences in cardiovascular disease outcomes. Methods: Caucasian individuals from two independent populations were assessed: 1) a prospective cohort of patients with acute coronary syndromes with 3-year mortality follow-up (n = 568) and 2) a nested case-control study from a randomized, controlled trial of hypertension patients with stable coronary disease in which the primary outcome was death, nonfatal myocardial infarction (MI) or nonfatal stroke (n = 619). Six CYP19A1 SNPs were genotyped (-81371 C>T, -45965 G>C, M201T, R264C, 80 A>G, and +32226 G>A). The sex*genotype interaction term was assessed for the primary outcome and compared by genotype in men and women when a significant interaction term was identified. Results: We identified a significant interaction between -81371 C>T and sex (p = 0.025) in the ACS population. The variant allele was associated with a 78% increase in mortality in men (HR 1.78, 95% confidence interval [CI] 1.08-2.94) and a nonsignificant 42% decrease in mortality among women (HR 0.58, 95% CI 0.22-1.54). We identified a similar association in the hypertensive CAD group, the -81371 C>T*sex interaction term was p<0.0001, with an associated 65% increase in death, MI, or stroke (HR 1.65, 95% CI 1.00-2.73) in men and a 69% decrease (HR 0.31, 95% CI 0.16-0.6) in women. Conclusions: Using two independent populations, this study is the first to document a significant interaction between CYP19A1 genotype and sex on cardiovascular outcomes. These findings could illuminate potential mechanisms of sex differences in cardiovascular disease outcomes.

Original languageEnglish
Article numbere15180
Pages (from-to)1-6
Number of pages6
JournalPloS one
Issue number12
StatePublished - 2010


Dive into the research topics of 'Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner'. Together they form a unique fingerprint.

Cite this